This inventor holds 1 USPTO granted patent. Top assignee: Rijksuniversiteit Leiden. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Maria Theodora Van Den Barselaar: Innovator in Antimicrobial Peptides
Introduction
Maria Theodora Van Den Barselaar is a notable inventor based in Wassenaar, Netherlands. She has made significant contributions to the field of antimicrobial research, particularly through her innovative work on peptides derived from ubiquicidine. Her research aims to enhance the treatment and prevention of infections in both humans and animals.
Latest Patents
Maria Theodora Van Den Barselaar holds a patent for her invention titled "Antimicrobial peptides derived from ubiquicidine." This invention relates to the use of ubiquicidine or modified peptide fragments derived from it for the preparation of drugs aimed at treating, diagnosing, or preventing infections. The patent details a peptide fragment that includes a continuous series of amino acids from the sequence of ubiquicidine, specifically KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPN ANS (SEQ ID NO: 1). The invention also encompasses hybrid molecules that combine cationic peptides with antimicrobial properties and effector molecules.
Career Highlights
Maria is affiliated with Rijksuniversiteit Leiden, where she continues her research and development in the field of antimicrobial peptides. Her work has garnered attention for its potential applications in medical and veterinary fields.
Collaborations
Some of her notable collaborators include Petrus Hendricus Nibbering and Pieter Sicco Hiemstra, who have contributed to her research endeavors.
Conclusion
Maria Theodora Van Den Barselaar is a pioneering inventor whose work on antimicrobial peptides has the potential to significantly impact the treatment of infections. Her contributions to science and medicine are commendable and highlight the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile